# Vaccination schedule

A vaccination schedule is a series of vaccinations, including the timing of all doses, which may be either recommended or compulsory, depending on the country of residence. A vaccine is an antigenic preparation used to produce active immunity to a disease, in order to prevent or reduce the effects of infection by any natural or "wild" pathogen. Vaccines go through multiple phases of trials to ensure safety and effectiveness.
Many vaccines require multiple doses for maximum effectiveness, either to produce sufficient initial immune response or to boost response that fades over time. For example, tetanus vaccine boosters are often recommended every 10 years. Vaccine schedules are developed by governmental agencies or physicians groups to achieve maximum effectiveness using required and recommended vaccines for a locality while minimizing the number of health care system interactions. Over the past two decades, the recommended vaccination schedule has grown rapidly and become more complicated as many new vaccines have been developed.
Some vaccines are recommended only in certain areas (countries, sub national areas, or at-risk populations) where a disease is common. For instance, yellow fever vaccination is on the routine vaccine schedule of French Guiana, is recommended in certain regions of Brazil but in the United States is only given to travelers heading to countries with a history of the disease. In developing countries, vaccine recommendations also take into account the level of health care access, the cost of vaccines and issues with vaccine availability and storage. Sample vaccination schedules discussed by the World Health Organization show a developed country using a schedule which extends over the first five years of a child's life and uses vaccines which cost over $700 including administration costs while a developing country uses a schedule providing vaccines in the first 9 months of life and costing only $25. This difference is due to the lower cost of health care, the lower cost of many vaccines provided to developing nations, and that more expensive vaccines, often for less common diseases, are not utilized.

## Worldwide

The World Health Organization monitors vaccination schedules across the world, noting what vaccines are included in each country's program, the coverage rates achieved and various auditing measures. The table below shows the types of vaccines given in example countries. The WHO publishes on its website current vaccination schedules for all WHO member states. Additional vaccines are given to individuals more likely to come into contact with specific diseases through work or travel (e.g. military), or after potentially infectious exposure. Examples include rabies, anthrax, cholera and smallpox.
Vaccines used for each infection in each country :
| Country Required for school Required for welfare Hepatitis A Hepatitis B Diphtheria Pertussis Tetanus Haemophilus influenzae Polio Measles Rubella Mumps Chickenpox Shingles Meningococcal Influenza Pneumococcal Encephalitis Cholera Human Papilloma Virus Japanese Encephalitis Rabies Rotavirus Tuberculosis Typhoid Fever Yellow fever Sources  AfghanistanDTwPHibHepB✓✓PCVRVBCG  AlbaniaDTwPHibHepB✓MMRIIVPCVRVBCG  Algeria✓DTwPHib✓MMRIIVPCVBCG  Andorra✓✓✓MMR✓✓IIVPCVHPV  AngolaDTwPHibHepB✓MRPCVRVBCGYF  Antigua and BarbudaDTwPHibHepB✓MMR✓IIVPCVHPVYF  ArgentinaYesHepADTwPHibHepB✓MMR✓✓IIVPCVHPVRabRVBCGYF  ArmeniaHepADTwPHibHepB✓MMR✓IIVPCVHPVRabRVBCG  AustraliaPreschool and daycare in NSW, Vic and WAYesHepAHepBDTaPHibMMRV✓IIVHPVRV  AustriaNoHepAHepBTdapIPVMMRIIVPCVHPVRV  AzerbaijanDTwPHibHepB✓MMRPCVBCG  BahamasHepADTwPHibHepB✓MMR✓IIVPCVHPVRVYF  BahrainHepADTwPHibHepB✓MMR✓IIVPCVCholHPVRVBCGYF  BangladeshDTwPHibHepB✓MRPCVHPVBCG  BarbadosHepADTwPHibHepB✓MMR✓IIVPCVHPVBCGYF  BelarusHepB✓✓✓Hib✓MMRIIVPCVBCG  BelgiumNurseries and daycareHepAHepBDTapHibIPVMMR✓IIVPCVHPVRV  BelizeDTwPHibHepB✓MMRIIVHPVRabBCGYF  BeninDTwPHibHepB✓MRPCVHPVBCGYF  BhutanDTwPHibHepB✓MMRHPVBCG  BoliviaDTwPHibHepB✓MMRIIVPCVHPVRVBCGYF  Bosnia and HerzegovinaHepAHepBDTaPHibIPVMMRIIVPCVBCGYF  BotswanaDTwPHibHepB✓MRPCVHPVRVBCG  BrazilNoYesHepADTwPHibHepB✓MMRV✓IIVPCVCholHPVRVBCGYF  BruneiHepBDTapHibIPVMRIIVHPVBCG  BulgariaHepBDTaPHibIPVMMRIIVPCVHPVRabRVBCG  Burkina FasoDTwPHibHepB✓MRPCVRVBCGYF  BurundiDTwPHibHepB✓MRPCVHPVRVBCGYF  Cape VerdeDTwPHibHepB✓MMRHPVBCGYF  CambodiaDTwPHibHepB✓MRHPVJEBCG  CameroonDTwPHibHepB✓MRPCVHPVRVBCGYF  CanadaIn New Brunswick and OntarioHepAHepBDTaPHibIPVMMRV✓✓IIVPCVHPVRVBCG  Central African RepublicHepB✓✓✓Hib✓✓PCVRVBCGYF  ChadDTwPHibHepB✓✓BCGYF  ChileHepADTwPHibHepB✓MMRIIVPCVHPVBCGYF  ChinaHepAHepBDTaP ✓✓JEBCG  ColombiaHepADTwPHibHepB✓MMR✓IIVPCVHPVRabRVBCGYF  ComorosDTwPHibHepB✓✓PCVBCG  CongoDTwPHibHepB✓MRPCVRVBCGYF  Cook IslandsDTaPHibHepBMRHPVBCG  Costa RicaHepBDTaPHibIPVMMR✓IIVPCVHPVRabRVBCG  Ivory CoastDTwPHibHepB✓MRIIVPCVHPVRVBCGYF  CroatiaNurseries, preschools and kindergartensHepBDTaP MMRIIVHPVBCG  CubaDTwPHibHepB✓MMR✓IIVBCG  CyprusHepAHepBDTapHibIPVMMR✓IIVPCVHPVBCGYF  Czech RepublicHepAHepBDTapHibIPVMMRIIVHPVBCG  North KoreaDTwPHibHepB✓✓BCG  DR CongoDTwPHibHepB✓✓PCVRVBCGYF  DenmarkNoHepBDTaPHibIPVMMRIIVPCVHPV  DjiboutiHepB✓✓✓Hib✓✓PCVRVBCG  DominicaHepB✓✓✓Hib✓MMRIIVHPVBCGYF  Dominican RepublicHepB✓✓✓Hib✓MMRIIVPCVHPVRabRVBCGYF  EcuadorDTwPHibHepB✓MMR✓IIVPCVHPVRVBCGYF  EgyptDTwPHibHepB✓MMR✓IIVPCVBCGYF  El SalvadorDTwPHibHepB✓MMRIIVPCVRVBCGYF  Equatorial GuineaDTwPHibHepB✓✓BCGYF  EritreaDTwPHibHepB✓MRPCVHPVRVBCG  EstoniaNoHepBDTapHibIPVMMRIIVHPVRVBCG  EswatiniDTwPHibHepB✓MRPCVHPVRVBCG  EthiopiaDTwPHibHepB✓✓PCVHPVRVBCG  FijiDTwPHibHepB✓MRHPVRVBCG  FinlandNoHepBDTaPHibIPVMMRVIIVPCVTBEHPVRVBCG  FranceYesHepBDTaPMMR✓✓IIVPCVHPVBCGYF  GabonDTwPHibHepB✓✓BCGYF  GambiaDTwPHibHepB✓MRPCVHPVRVBCGYF  GeorgiaHepB✓✓✓✓MMRIIVPCVHPVRVBCG  GermanyNoHepBDTaPHibIPVMMRV✓✓IIVPCVHPVRV  GhanaHepB✓✓✓Hib✓MRPCVRVBCGYF  GreeceHepAHepBDTaP MMRV✓IIVPCVHPVRVBCG  GrenadaDTwPHibHepB✓MMR✓IIVHPVYF  GuatemalaDTwPHibHepB✓MMRIIVPCVHPVRVBCGYF  GuineaDTwPHibHepB✓✓BCGYF  Guinea-BissauDTwPHibHepB✓✓PCVRVBCGYF  GuyanaDTwPHibHepB✓MMR✓PCVHPVRVBCGYF  HaitiDTwPHibHepB✓MRPCVRVBCG  HondurasHepADTwPHibHepB✓MMRIIVPCVHPVRVBCGYF  Hong KongHepBDTaPIPVMMR✓PCVHPVBCG  HungaryNoHepBDTaPHibIPVMMRIIVPCVHPVBCG  IcelandNoHepBDTaPHibIPVMMR✓IIVPCVHPV  IndiaDTwPHibHepB✓MRJERVBCG  IndonesiaDTwPHibHepB✓MRHPVJEBCG MMR  IranDTwPHibHepB✓MMR✓IIVPCVBCGYF  IraqHepAHepBDTaPHibIPVMMRIIVPCVRVBCG  IrelandNoHepBTDaPMMR✓IIVPCVHPVRVBCG  IsraelHepAHepBDTaPHibIPVMMRV✓IIVPCVTBEHPVJERVBCGTFYF  ItalyYesHepADTaPHepBIPVHibMMRV✓✓IIVPCVHPVRVBCG  JamaicaHepBDTaPHibIPVMMRIIVPCVHPVBCGYF  JapanNoHepBDTapHibIPVMR✓IIVHPVJEBCG  JordanHepB✓✓✓Hib✓MMRIIVRVBCG  KazakhstanHepAHepBDTaPHibIPVMMRIIVPCVTBERabBCG  KenyaDTwPHibHepB✓MRIIVPCVHPVRVBCGYF  KiribatiDTwPHibHepB✓MRIIVRVBCG  KuwaitHepADTwPHibHepB✓MMRV✓IIVPCVRVBCGTFYF  KyrgyzstanDTwPHibHepB✓MMRPCVRVBCG  LaosDTwPHibHepB✓MRIIVHPVJERVBCG  LatviaNoHepBDTaPHibIPVMMR✓IIVPCVTBEHPVRabRVBCG  LebanonDTwPHibHepB✓MMRIIVPCV  LesothoDTwPHibHepB✓MRPCVRVBCGYF  LiberiaDTwPHibHepB✓✓PCVHPVRVBCGYF  LibyaHepBDTaPHibIPVMMRIIVPCVHPVRVBCGYF  LithuaniaNoHepBDTaPHibIPVMMRIIVPCVHPVRabRVBCG  LuxembourgDTaPHibIPVMMRV✓IIVPCVHPVRVTFYF  MadagascarDTwPHibHepB✓✓PCVRVBCG  MalawiDTwPHibHepB✓MRPCVHPVRVBCG  MalaysiaHepBDTaPHibIPVMRIIVHPVJEBCGYF  MaldivesDTwPHibHepB✓MRHPVBCGYF  MaliDTwPHibHepB✓✓PCVHPVRVBCGYF  MaltaHepBDTaPHibIPVMMRIIVPCVHPVBCG  Marshall IslandsDTaPHepBIPVMR✓IIVHPVRVBCG  MauritaniaDTwPHibHepB✓MRPCVHPVRVBCG  MauritiusHepAHepB✓✓✓MMRIIVPCVHPVRVBCG  MexicoHepAHepBDTaPHibIPVMMR✓IIVPCVHPVRVBCG  MicronesiaDTaPHepBIPVMRHPVRVBCG  MonacoHepB✓✓Hib✓MMR✓IIVPCVHPV  MongoliaHepADTwPHibHepB✓MRIIVBCG  MontenegroHepBDTaPHibIPVMMRIIVBCG  MoroccoDTwPHibHepB✓MRIIVPCVRVBCG  MozambiqueDTwPHibHepB✓MRPCVRVBCG  MyanmarDTwPHibHepB✓MRJEBCG  NamibiaDTwPHibHepB✓MRPCVRVBCG  NauruDTwPHibHepB✓MRBCG  NepalDTwPHibHepB✓MRJEBCG  NetherlandsNoHepBDTapHibIPVMMR✓IIVPCVHPV  New ZealandHepAHepBDTapHibIPVMMR✓✓IIVHPVRVBCG  NicaraguaDTwPHibHepB✓MMRIIVPCVRVBCGYF  NigerDTwPHibHepB✓✓PCVRVBCGYF  NigeriaDTwPHibHepB✓✓PCVHPVRVBCGYF  NiueDTwPHepBIPVMRIIVRVBCG  North MacedoniaHepBDTaPHibIPVMMRIIVHPVBCG  NorwayNoHepBDTapHibIPVMMRIIVPCVHPVRVBCG  OmanDTwPHibHepB✓MMR✓IIVPCVBCGTFYF  PakistanDTwPHibHepB✓✓PCVRVBCG  PalauDTaPHepBIPVMRIIVHPVRV  PanamaHepAHepBDTwPHibMMR✓IIVPCVHPVRabRVBCGYF  Papua New GuineaDTwPHibHepB✓MRHPVBCG  ParaguayHepADTwPHibHepB✓MMR✓✓IIVPCVHPVRVBCGYF  PeruDTwPHibHepB✓MMR✓IIVPCVHPVRVBCGYF  PhilippinesDTwPHibHepB✓MRIIVHPVBCG  PolandNoHepBDTaPHibIPVMMR✓IIVPCVRabBCG  PortugalNoHepBDTaPHibIPVMMR✓IIVPCVHPVRabBCGYF  QatarHepADTwPHibHepB✓MMR✓IIVPCVRVBCG  South KoreaHepAHepBDTaPHibIPVMR✓IIVHPVJEBCGTF  MoldovaDTwPHibHepB✓MMRIIVPCVHPVRVBCG  RomaniaNoHepBDTapHibIPVMMR✓IIVPCVRVBCGYF  RussiaNoHepAHepBDTaPHibIPVMMR✓IIVPCVHPVRVBCGYF  RwandaDTwPHibHepB✓MRPCVHPVRVBCG  Saint Kitts and NevisDTwPHibHepB✓MMRIIVHPVBCGYF  Saint LuciaDTwPHibHepB✓MMR✓IIVPCVHPVBCGYF  Saint Vincent and the GrenadinesDTwPHibHepB✓MMRHPVBCGYF  SamoaDTwPHibHepB✓MRBCG  San MarinoHepAHepBDTapHibIPVMMR✓✓IIVPCVCholHPVJERabYF  São Tomé and PríncipeDTwPHibHepB✓MRPCVHPVRVBCGYF  Saudi ArabiaHepAHepBDTaPHibMMR✓IIVPCVRVBCGYF  SenegalDTwPHibHepB✓MRPCVHPVRVBCGYF  SerbiaHepAHepBDTaPHibIPVMMRIIVPCVBCGTFYF  SeychellesDTwPHibHepB✓MMRPCVHPVRVBCGYF  Sierra LeoneDTwPHibHepB✓MRPCVHPVRVBCGYF  SingaporeHepBDTaPHibIPVMRIIVHPVBCG  SlovakiaNoHepBDTapHibIPVMMRIIVPCV  SloveniaNoHepBDTaPHibIPVMMR✓IIVPCVTBEHPVRabBCG  Solomon IslandsDTwPHibHepB✓MRHPVBCG  SomaliaDTwPHibHepB✓✓BCG  South AfricaNoHepB✓✓✓✓IIVPCVHPVRVBCG  South SudanDTwPHibHepB✓✓BCG  SpainNoHepAHepBTDaPMMRV✓✓IIVPCVCholHPVJEYF  Sri LankaDTwPHibHepB✓MRHPVJEBCGYF  SudanDTwPHibHepB✓✓✓PCVRVBCG  SurinameDTwPHibHepB✓MMRIIVHPVRabYF  SwedenNoHepBDTapHibIPVMMRIIVPCVHPVRVBCG  SwitzerlandNoHepBDTaPHibIPVMMR✓✓IIVPCVHPV  SyriaDTwPHibHepB✓MMR✓IIVBCG  TajikistanDTwPHibHepB✓MRIIVRVBCG  TanzaniaDTwPHibHepB✓MRPCVHPVRVBCG  ThailandHepB✓✓MRIIVHPVJERVBCG  Timor-LesteDTwPHibHepB✓MRRVBCG  TogoDTwPHibHepB✓MRPCVHPVRVBCGYF  TongaDTwPHibHepB✓MRHPVRVBCG  Trinidad and TobagoDTwPHibHepB✓MMR✓IIVPCVHPVYF  TunisiaHepADTwPHibHepB✓MRIIVBCG  TurkeyHepAHepBDTaPHibIPVMMR✓IIVPCVBCG  TurkmenistanHepADTwPHibHepB✓MMRIIVPCVHPVRVBCG  TuvaluDTwPHibHepB✓MRIIVBCG  UgandaDTwPHibHepB✓MRPCVHPVRVBCG  UkraineYesDTwPHibHepB✓MMRIIVBCG  United Arab EmiratesHepADTwPHibHepB✓MMR✓✓IIVPCVCholRVBCGYF  United KingdomNoHepBDTapHibIPVMMR✓✓IIVPCVHPVRabRVBCG  United StatesYesHepADTaPHepBIPVMMRV✓IIVPCVHPVRV  UruguayHepADTwPHibHepB✓MMR✓IIVPCVHPVBCGYF  UzbekistanDTwPHibHepB✓MMRIIVPCVRVBCG  VanuatuDTwPHibHepB✓MRHPVBCG  VenezuelaDTwPHibHepB✓MMR✓IIVPCVRabRVBCGYF  VietnamDTwPHibHepB✓MRIIVJEBCG  YemenDTwPHibHepB✓MRPCVRVBCG  ZambiaDTwPHibHepB✓MRPCVRVBCG  ZimbabweDTwPHibHepB✓MRPCVHPVRVBCG |||||
| Mandatory to all | Mandatory to specific people | Recommended to all | Recommended to specific people | Neither mandatory nor recommended to anyone |
| ↑ Category B (i.e. not even recommended but for a personal care only) for the elderly. The public insurance partially covers the vaccination cost. |||||

## By country
### Australia

The Immunise Australia Program implements the National Immunization Program (NIP) Schedule. All vaccines available under the Australian immunization schedule are free of charge under the Pharmaceutical Benefits Scheme.
Vaccine Schedule for Australia: 1 April 2019 :
| Infection | Birth | Months | Months | Months | Months | Months | Years | Years | Years | Years | Years | Years | Years | Preg Women |
| Infection | Birth | 2 | 4 | 6 | 12 | 18 | 4 | 12–<13 | 14–<16 | >15 | >50 | 65+ | 70 | Preg Women |
| Rotavirus | | RV† | RV† | | | | | | | | | | | |
| Hepatitis A | | | | | HepA§ | HepA§ | | | | | | | | |
| Hepatitis B | HepB† | DTaP-HepB-IPV-Hib† | DTaP-HepB-IPV-Hib† | DTaP-HepB-IPV-Hib† | DTaP-HepB-IPV-Hib‡ | DTaP-HepB-IPV-Hib‡ | DTaP-HepB-IPV-Hib‡ | DTaP-HepB-IPV-Hib‡ | DTaP-HepB-IPV-Hib‡ | DTaP-HepB-IPV-Hib‡ | | | | |
| Diphtheria | | DTaP-HepB-IPV-Hib† | DTaP-HepB-IPV-Hib† | DTaP-HepB-IPV-Hib† | DTaP-HepB-IPV-Hib‡ | DTaP-HepB-IPV-Hib‡ | DTaP-HepB-IPV-Hib‡ | Tdap† | DTaP-HepB-IPV-Hib‡ | DTaP-HepB-IPV-Hib‡ | | | | Tdap† |
| Pertussis | | DTaP-HepB-IPV-Hib† | DTaP-HepB-IPV-Hib† | DTaP-HepB-IPV-Hib† | DTaP-HepB-IPV-Hib‡ | DTaP-HepB-IPV-Hib‡ | DTaP-HepB-IPV-Hib‡ | Tdap† | DTaP-HepB-IPV-Hib‡ | DTaP-HepB-IPV-Hib‡ | | | | Tdap† |
| Tetanus | | DTaP-HepB-IPV-Hib† | DTaP-HepB-IPV-Hib† | DTaP-HepB-IPV-Hib† | DTaP-HepB-IPV-Hib‡ | DTaP-HepB-IPV-Hib‡ | DTaP-HepB-IPV-Hib‡ | Tdap† | DTaP-HepB-IPV-Hib‡ | DTaP-HepB-IPV-Hib‡ | | | | Tdap† |
| Polio | | DTaP-HepB-IPV-Hib† | DTaP-HepB-IPV-Hib† | DTaP-HepB-IPV-Hib† | DTaP-HepB-IPV-Hib‡ | DTaP-HepB-IPV-Hib‡ | DTaP-HepB-IPV-Hib‡ | DTaP-HepB-IPV-Hib‡ | DTaP-HepB-IPV-Hib‡ | DTaP-HepB-IPV-Hib‡ | | | | |
| Haemophilus influenzae | | DTaP-HepB-IPV-Hib† | DTaP-HepB-IPV-Hib† | DTaP-HepB-IPV-Hib† | DTaP-HepB-IPV-Hib‡ | DTaP-HepB-IPV-Hib‡ | DTaP-HepB-IPV-Hib‡ | DTaP-HepB-IPV-Hib‡ | DTaP-HepB-IPV-Hib‡ | DTaP-HepB-IPV-Hib‡ | | | | |
| Meningococcus | | | | | MenACWY† | MenACWY‡ | MenACWY‡ | MenACWY‡ | MenACWY† | MenACWY‡ | | | | |
| Pneumococcus | | PCV13† | PCV13† | PCV13# | PCV13† | PCV13‡ | PCV13‡ | PCV13‡ | PCV13‡ | PCV13‡ | | | | |
| Pneumococcus | | PCV13† | PCV13† | PCV13§ | PCV13† | PCV13‡ | PCV13‡ | PCV13‡ | PCV13‡ | PCV13‡ | | | | |
| Pneumococcus | | | | | | | PPSV23# | | | PPSV23#§ | PPSV23§ | PPSV23† | | |
| Measles | | | | | MMR† | MMRV† | MMRV‡ | MMRV‡ | MMRV‡ | MMRV‡ | | | | |
| Mumps | | | | | MMR† | MMRV† | MMRV‡ | MMRV‡ | MMRV‡ | MMRV‡ | | | | |
| Rubella | | | | | MMR† | MMRV† | MMRV‡ | MMRV‡ | MMRV‡ | MMRV‡ | | | | |
| Varicella | | | | | | MMRV† | MMRV‡ | MMRV‡ | MMRV‡ | MMRV‡ | | | | |
| Human papillomavirus | | | | | | | | HPV x2† | HPV x2‡ | HPV x2‡ | | | | |
| Influenza | | | | IIV (yearly)† | IIV (yearly)† | IIV (yearly)† | IIV (yearly)† | | | | | IIV (yearly)† | IIV (yearly)† | IIV (yearly)† |
| IIV (yearly)† ||||
| IIV (yearly)† ||||
| Herpes Zoster | | | | | | | | | | | | | ZVL | |
| † Recommended ages for everyone. # Recommended ages for certain other high-risk groups. ‡ Recommended ages for catch-up immunization. § Recommended range of additional vaccinations for Aboriginals and Torres Strait Islanders. 1 2 3 Queensland, Northern Territory, Western Australia, South Australia 1 2 3 4 5 All people aged less than 20 years are eligible for free catch up vaccines. |||||||||||||||

### Austria

Austrian vaccine recommendations are developed by the National Vaccination Board (German: Nationales Impfgremium), which is part of the Federal Ministry of Social Affairs, Health, Care and Consumer Protection.
Children aged 14 and older can be vaccinated without parental consent.

### Brazil

All recommended vaccines are provide free of charge by the public health services.
Brazilian National Vaccination Schedule: 2019 :
| Infection | Gestation | Birth | Months | Months | Months | Months | Months | Months | Months | Months | Years | Years | Years | Years | Years | Years |
| Infection | Gestation | Birth | 2 | 3 | 4 | 5 | 6 | 9 | 12 | 15 | 4 | 5 | 9 | 11 | 10–59 | 60+ |
| Tuberculosis | | BCG | | | | | | | | | | | | | | |
| Leprosy | | BCG | | | | | | | | | | | | | | |
| Hepatitis A | | | | | | | | | | HepA | | | | | | |
| Hepatitis B | | HepB | 5V | | 5V | | 5V | | | | | | | | | |
| Diphtheria | DTPa | | 5V | | 5V | | 5V | | | DTP | DTP | | | | dT | dT |
| Tetanus | DTPa | | 5V | | 5V | | 5V | | | DTP | DTP | | | | dT | dT |
| Pertussis | DTPa | | 5V | | 5V | | 5V | | | DTP | DTP | | | | dT | dT |
| Haemophilus influenzae | | | 5V | | 5V | | 5V | | | | | | | | | |
| Polio | | | IPV | | IPV | | IPV | | | OPV | OPV | | | | | |
| Pneumococcus | | | 10v | | 10v | | | | 10v | | | | | | | |
| Meningococcus | | | | MenC | | MenC | | | MenC | | | | | MenC | | |
| Rotavirus | | | RV | | RV | | | | | | | | | | | |
| Measles | | | | | | | | | MMR | MMRV | | | | | | |
| Mumps | | | | | | | | | MMR | MMRV | | | | | | |
| Rubella | | | | | | | | | MMR | MMRV | | | | | | |
| Varicella | | | | | | | | | | MMRV | VV | | | | |
| Yellow fever | | | | | | | | YF | | | | | | | | |
| Human papillomavirus | | | | | | | | | | | | | HPV x2 (girls) | HPV x2 (boys) | | |
| Flu | IIV | | | | | | IIV (yearly) | IIV (yearly) | IIV (yearly) | IIV (yearly) | IIV (yearly) | | | | | IIV (yearly) |

### Canada

In Canada, publicly funded immunization schedules may vary from province or territory.

#### Alberta

Alberta Vaccine Schedule: 2015 :
| Infection | Months | Months | Months | Months | Months | Years | Years | Years | Years |
| Infection | 2 | 4 | 6 | 12 | 18 | 4 | 10–13 | 15–17 | 65+ |
| Hepatitis B | | | | | | HepB | | | |
| Diphtheria | DTaP | DTaP | DTaP | | DTaP | DTaP | | Tdap | |
| Tetanus | DTaP | DTaP | DTaP | | DTaP | DTaP | | Tdap | |
| Pertussis | DTaP | DTaP | DTaP | | DTaP | DTaP | | Tdap | |
| Haemophilus influenzae | HIB | HIB | HIB | | HIB | | | | |
| Pneumococcus | PneuC13 | PneuC13 | | PneuC13 | | | | | |
| Polio | IPV | IPV | IPV | | IPV | IPV | | | |
| Measles | | | | MMRV | | MMRV | | | |
| Mumps | | | | MMRV | | MMRV | | | |
| Rubella | | | | MMRV | | MMRV | | | |
| Varicella | | | | MMRV | | MMRV | | | |
| Meningococcus | | MenC | | MenC | | | | MenC-ACYW | |
| Human papillomavirus | | | | | | | HPV | HPV (boys) | |
| Flu | | | IIV (yearly) | IIV (yearly) | IIV (yearly) | IIV (yearly) | IIV (yearly) | IIV (yearly) | IIV (yearly) |

#### British Columbia

British Columbia Vaccine Schedule: 2015 :
| Infection | Months | Months | Months | Months | Months | Years | Years | Years | Years |
| Infection | 2 | 4 | 6 | 12 | 18 | 4 | 10–13 | 15–17 | 65+ |
| Hepatitis B | HepB | HepB | HepB | | | | | | |
| Rotavirus | RV | RV | | | | | | | |
| Diphtheria | DTaP | DTaP | DTaP | | | DTaP | | Tdap | |
| Tetanus | DTaP | DTaP | DTaP | | | DTaP | | Tdap | |
| Pertussis | DTaP | DTaP | DTaP | | | DTaP | | Tdap | |
| Haemophilus influenzae | HIB | HIB | HIB | | HIB | | | | |
| Pneumococcus | PneuC13 | PneuC13 | | PneuC13 | | | | | |
| Polio | IPV | IPV | IPV | | IPV | IPV | | | |
| Measles | | | | MMR | | MMRV | | | |
| Mumps | | | | MMR | | MMRV | | | |
| Rubella | | | | MMR | | MMRV | | | |
| Varicella | | | | | | MMRV | VV | | |
| Meningococcus | MenCCV | | | MenCCV | | | | | |
| Human papillomavirus | | | | | | | HPV (girls) | | |
| Flu | | | IIV (yearly) | IIV (yearly) | IIV (yearly) | IIV (yearly) | IIV (yearly) | IIV (yearly) | IIV (yearly) |

#### New Brunswick

New Brunswick Vaccine Schedule: 2015 :
| Infection | Birth | Months | Months | Months | Months | Months | Years | Years | Years | Years |
| Infection | Birth | 2 | 4 | 6 | 12 | 18 | 4 | 10–13 | 15–17 | 65+ |
| Hepatitis B | HepB | HepB | | HepB | | | | | | |
| Diphtheria | | DTaP | DTaP | DTaP | | DTaP | DTaP | | Tdap | |
| Tetanus | | DTaP | DTaP | DTaP | | DTaP | DTaP | | Tdap | |
| Pertussis | | DTaP | DTaP | DTaP | | DTaP | DTaP | | Tdap | |
| Haemophilus influenzae | | HIB | HIB | HIB | | HIB | | | | |
| Pneumococcus | | PneuC13 | PneuC13 | | PneuC13 | | | | | |
| Polio | | IPV | IPV | IPV | | IPV | IPV | | | |
| Measles | | | | | MMRV | MMRV | | | | |
| Mumps | | | | | MMRV | MMRV | | | | |
| Rubella | | | | | MMRV | MMRV | | | | |
| Varicella | | | | | MMRV | MMRV | | | | |
| Meningococcus | | | | | MenCCV | | | | MenC-ACYW | |
| Human papillomavirus | | | | | | | | HPV (girls) | | |
| Flu | | | | IIV (yearly) | IIV (yearly) | IIV (yearly) | IIV (yearly) | IIV (yearly) | IIV (yearly) | IIV (yearly) |

#### Ontario

Ontario Vaccine Schedule: 2017 :
| Infection | Months | Months | Months | Months | Months | Months | Years | Years | Years |
| Infection | 2 | 4 | 6 | 12 | 15 | 18 | 4 | 10–13 | 15–17 |
| Hepatitis B | | | | | | | | HepB | |
| Rotavirus | RV | RV | | | | | | | |
| Diphtheria | DTaP | DTaP | DTaP | | | DTaP | DTaP | | Tdap |
| Tetanus | DTaP | DTaP | DTaP | | | DTaP | DTaP | | Tdap |
| Pertussis | DTaP | DTaP | DTaP | | | DTaP | DTaP | | Tdap |
| Haemophilus influenzae | HIB | HIB | HIB | | | HIB | | | |
| Pneumococcus | PCV13 | PCV13 | | PCV13 | | | | | |
| Polio | IPV | IPV | IPV | | | IPV | IPV | | |
| Measles | | | | MMRV | | | MMRV | | |
| Mumps | | | | MMRV | | | MMRV | | |
| Rubella | | | | MMRV | | | MMRV | | |
| Varicella | | | | MMRV | VV | | MMRV | | |
| Meningococcus | | | | MenC | | | | MenC-ACYW | |
| Human papillomavirus | | | | | | | | HPV (girls) | |

#### Quebec

Quebec Vaccine Schedule: 2019 :
| Infection | Months | Months | Months | Months | Months | Years | Years | Years | Years | Years | Years | Years |
| Infection | 2 | 4 | 6 | 12 | 18 | 4–6 | 9 | 14–16 | Adult | 50 | 65 | 75 |
| Hepatitis A | | | | | | | HepA | | | | | |
| Hepatitis B | HepB | HepB | | | HepB | | HepB | | | | | |
| Rotavirus | RV | RV | | | | | | | | | | |
| Diphtheria | DTaP | DTaP | DTaP | | DTaP | Tdap | | Tdap | Tdap | Tdap | | |
| Tetanus | DTaP | DTaP | DTaP | | DTaP | Tdap | | Tdap | Tdap | Tdap | | |
| Pertussis | DTaP | DTaP | DTaP | | DTaP | Tdap | | Tdap | Tdap | Tdap | | |
| Haemophilus influenzae | HIB | HIB | HIB | | HIB | | | | | | | |
| Pneumococcus | PCV10 | PCV10 | | PCV10 | | | | | | | PPV23 | |
| Polio | IPV | IPV | IPV | | IPV | IPV | | | | | | |
| Measles | | | | MMR | MMRV | | | | | | | |
| Mumps | | | | MMR | MMRV | | | | | | | |
| Rubella | | | | MMR | MMRV | | | | | | | |
| Varicella | | | | | MMRV | VV | | | | | | |
| Meningococcus | | | | MenCC | | | | MenCC | | | | |
| Human papillomavirus | | | | | | | HPV | | | | | |
| Flu | | | IIV | IIV | IIV | | | | | | | IIV (yearly) |

### Finland

Vaccination Schedule for Finland :
| Infection | Birth | Months | Months | Months | Months | Months | Months | Years | Years | Years | Years | Years | Years | Years |
| Infection | Birth | 2 | 3 | 5 | 6 | 12 | 18 | 3 | 4 | 6 | 11–12 | 14–15 | 25 | 65+ |
| Tuberculosis | BCG | | | | | | | | | | | | | |
| Rotavirus | | RV | RV | RV | | | | | | | | | | |
| Diphtheria | | | DTaP | DTaP | | DTaP | | | DTaP | | | Tdap | Td (10‑yearly) | |
| Tetanus | | | DTaP | DTaP | | DTaP | | | DTaP | | | Tdap | Td (10‑yearly) | |
| Pertussis | | | DTaP | DTaP | | DTaP | | | DTaP | | | Tdap | | |
| Polio | | | IPV | IPV | | IPV | | | IPV | | | | | |
| Haemophilus influenzae | | | HIB | HIB | | HIB | | | | | | | | |
| Hepatitis B | HepB | | | | | | | | | | | | | |
| Pneumococcus | | | PCV10 | PCV10 | | PCV10 | | | | | | | | PCV13 + PPSV23 |
| Measles | | | | | | MMR | MMR | | | MMRV | | | | |
| Mumps | | | | | | MMR | MMR | | | MMRV | | | | |
| Rubella | | | | | | MMR | MMR | | | MMRV | | | | |
| Varicella | | | | | | | VV | | | MMRV | | | | |
| Human papillomavirus | | | | | | | | | | | HPV | | | |
| Influenza | | | | | IIV3 | IIV3 | IIV3 | IIV3 | | | | | | IIV3 |
| Tick-borne encephalitis | | | | | | | | TBE | TBE | TBE | TBE | TBE | TBE | TBE |
| ↑ For specific at risk-groups only (to be given at the earliest age)) ↑ Thereafter Td booster every 10 years with or without vaccination against poliomyelitis (IPV) in case of travel to endemic areas and when previous IPV dose was given more than 5 years before ↑ Recommended but not free of charge for those over 65 years. ↑ Vaccination can be given from 6 months of age in case of travel abroad. If vaccination starts before 12 months of age, 2 doses are recommended (14–18 months and 6 years) The temporary recommendation of giving measles at 12 months of age was made a permanent recommendation; ie. now MMR should be given from 12–18 months except if travelling abroad to measles infected countries when it can be given from 6 months on. In case MMR is given at 6–11 months, the child needs a second and third dose to complete the series. ↑ Varicella vaccination implemented from 1 September 2017. Catch-up to all those born on 1 January 2006 or after and with no history of varicella. ↑ One or two doses administered depending on previous influenza vaccination history. Annual vaccination. IIV tri-or quadrivalent used as follows: IIV3 for all those 6–35 months. IIV4 with nonpreferential alternative to all those 24–35 months. IIV3 also recommended to medical risk group children from 36 months up. ↑ TBE vaccination for to those living permanently on the island of Åland |||||||||||||||

#### History

    1960: Mumps vaccinations for military recruits.
    1975: Measles vaccination for 1 year old children.
    1975: Rubella vaccination for 11–13 years old girls and seronegative mothers.
    1982: Two doses of MMR vaccination at 14–18 months and 6 years of age were introduced in the national childhood vaccination programme.
    2009: Rotavirus vaccine introduced at 2, 3 and 5 months to all children (September 2009)
    2010: PCV introduced at 3, 5 and 12 months of age to all children (September 2010).
    2013: HPV vaccination of girls introduced
    2017: Varicella vaccination introduced (1 September 2017) at 18 months, 6 years + catch-up of all born from 1 January 2006 or after with no history of varicella.
    2020: HPV vaccination of boys introduced

### France

Vaccination Schedule for France :
| Infection | Months | Months | Months | Months | Months | Months | Months | Months | Months | Months | Months | Years | Years | Years | Years | Years | Years | Years |
| Infection | 0 | 1 | 2 | 4 | 6 | 11 | 12 | 13 | 15 | 16–18 | 23 | 2 | 5 | 6 | 11–13 | 25 | 45 | 65+ |
| Tuberculosis | BCG† | | BCG# | BCG# | BCG# | BCG# | BCG# | BCG# | BCG# | BCG# | BCG# | BCG# | BCG# | BCG# | BCG# | | | |
| Diphtheria | | | D† | D† | | D† | | | | | | | | D† | D† | d† | d† | d† |
| Tetanus | | | TT† | TT† | | TT† | | | | | | | | TT† | TT† | TT† | TT† | TT† |
| Pertussis | | | acP† | acP† | | acP† | | | | | | | | acP† | acP† | acp† | | |
| Polio | | | IPV† | IPV† | | IPV† | | | | | | | | IPV† | IPV† | IPV† | IPV† | IPV† |
| Haemophilus influenzae | | | Hib† | Hib† | | Hib† | | | | | | | | | | | | |
| Hepatitis B | HepB† | HepB† | HepB† | HepB† | HepB† | | | | | | | | | | | | | |
| Pneumococcus | | | PCV† | PCV† | | PCV† | | | | | | | | | | | | |
| Meningococcus | | | | | | | MenC† | MenC† | MenC† | MenC† | MenC† | | | | | | | |
| Measles | | | | | MEAS† | MEAS† | MEAS† | | | MEAS† | | | | | | | | |
| Mumps | | | | | | | MUMPS† | | | MUMPS† | | | | | | | | |
| Rubella | | | | | | | RUMBE† | | | RUMBE† | | | | | | | | |
| Human papillomavirus | | | | | | | | | | | | | | | HPV† | | | |
| Influenza | | | | | | | | | | | | | | | | | | TIV† |
| Herpes Zoster | | | | | | | | | | | | | | | | | | HZ† |
| † General Recommendation # Recommended for specific groups only. ‡ Catch-up |||||||||||||||||||

### Germany

In Germany, a vaccination schedule is developed by the Standing Committee on Vaccination (STIKO), which operates as part of the Robert Koch Institute. The recommendations are generally adopted by the Federal Joint Committee.
Vaccination Schedule for Germany :
| Infection | Weeks | Months | Months | Months | Months | Months | Months | Months | Months | Years | Years | Years | Years | Years | Years | Years | Years | Years |
| Infection | 6 | 2 | 3 | 4 | 11 | 12 | 14 | 15 | 23 | 2 | 5–6 | 9 | 14 | 15 | 17 | 18–45 | 59 | >60 |
| Rotavirus | RV† | RV† | RV† | RV† | | | | | | | | | | | | | | |
| Diphtheria | | D† | D† | D† | D† | D† | D† | D‡ | D‡ | d‡ | d† | d† | d† | d† | d† | d† | d† | d† |
| Tetanus | | TT† | TT† | TT† | TT† | TT† | TT† | TT‡ | TT‡ | TT‡ | TT† | TT† | TT† | TT† | TT† | TT† | TT† | TT† |
| Pertussis | | acP† | acP† | acP† | acP† | acP† | acP† | acP‡ | acP‡ | acP‡ | acp† | acp† | acp† | acp† | acp† | acp† | acp† | acp† |
| Polio | | IPV† | IPV† | IPV† | IPV† | IPV† | IPV† | IPV‡ | IPV‡ | IPV‡ | | IPV† | IPV† | IPV† | IPV† | IPV‡ | IPV‡ | IPV‡ |
| Haemophilus influenzae | | Hib† | Hib† | Hib† | Hib† | Hib† | Hib† | Hib‡ | Hib‡ | Hib‡ | | | | | | | | |
| Hepatitis B | | HepB† | HepB† | HepB† | HepB† | HepB† | HepB† | HepB‡ | HepB‡ | HepB‡ | HepB‡ | HepB‡ | HepB‡ | HepB‡ | HepB‡ | | | |
| Pneumococcus | | PCV† | PCV† | PCV† | PCV† | PCV† | PCV† | PCV‡ | PCV‡ | | Pnc# | Pnc# | Pnc# | Pnc# | Pnc# | Pnc# | Pnc# | PPSV23† |
| Meningococcus | | | | | | MenC† | MenC† | MenC† | MenC† | MenC‡ | MenC‡ | MenC‡ | MenC‡ | MenC‡ | MenC‡ | | | |
| Measles | | | | | MEAS† | MEAS† | MEAS† | MEAS† | MEAS† | MEAS‡ | MEAS‡ | MEAS‡ | MEAS‡ | MEAS‡ | MEAS‡ | MEAS# | | |
| Mumps | | | | | MUMPS† | MUMPS† | MUMPS† | MUMPS† | MUMPS† | MUMPS‡ | MUMPS‡ | MUMPS‡ | MUMPS‡ | MUMPS‡ | MUMPS‡ | | | |
| Rubella | | | | | RUMBE† | RUMBE† | RUMBE† | RUMBE† | RUMBE† | RUMBE‡ | RUMBE‡ | RUMBE‡ | RUMBE‡ | RUMBE‡ | RUMBE‡ | | | |
| Varicella | | | | | VAR† | VAR† | VAR† | VAR† | VAR† | VAR‡ | VAR‡ | VAR‡ | VAR‡ | VAR‡ | VAR‡ | | | |
| Human papillomavirus | | | | | | | | | | | | HPV† | HPV† | HPV‡ | HPV‡ | | | |
| Influenza | | | | | | | | | | | | | | | | | | TIV† |
| Tick-borne Encephalitis | | | | | | TBE# | TBE# | TBE# | TBE# | TBE# | TBE# | TBE# | TBE# | TBE# | TBE# | TBE# | TBE# | TBE# |
| † General Recommendation # Recommended for specific groups only. ‡ Catch-up |||||||||||||||||||

### Hong Kong

In Hong Kong, Department of Health is responsible for providing free vaccinations from newborns up to primary school students.

### India

In India, the standard vaccination schedule is recommended by the Indian Academy of Paediatrics(IAP). The latest schedule was the one given in 2016.
IAP Immunization Timetable: 2016 :
| Infection | Birth | Months | Months | Months | Months | Months | Months | Months | Months | Months | Months | Years | Years | Years |
| Infection | Birth | 1.5 | 2.5 | 3.5 | 6 | 9 | 9-12 | 12 | 15 | 16-18 | 18 | 2 | 4–6 | 10–12 |
| Tuberculosis | BCG | | | | | | | | | | | | | |
| Polio | OPV | | | | OPV | OPV | | | | | | | OPV | |
| Hepatitis B | HepB | HepB | | | HepB | | | | | | | | | |
| Rotavirus | | RV | RV | RV | | | | | | | | | | |
| Diphtheria | | DTwP | DTwP | DTwP | | | | | | DTwP | | | DTwP | Tdap |
| Tetanus | | DTwP | DTwP | DTwP | | | | | | DTwP | | | DTwP | Tdap |
| Pertussis | | DTwP | DTwP | DTwP | | | | | | DTwP | | | DTwP | Tdap |
| Haemophilus influenzae | | HIB | HIB | HIB | | | | | | HIB | | | | |
| Pneumococcus | | PCV | PCV | PCV | | | | | PCV | | | | | |
| Polio | | IPV | IPV | IPV | | | | | | IPV | | | | |
| Measles | | | | | | MMR | | | MMR | | | | MMR | |
| Mumps | | | | | | MMR | | | MMR | | | | MMR | |
| Rubella | | | | | | MMR | | | MMR | | | | MMR | |
| Typhoid | | | | | | | TCV | | | | | TCV | | |
| Hepatitis A | | | | | | | | HepA | | | HepA | | | |
| Varicella | | | | | | | | | VV | | | | VV | |
| Human papillomavirus | | | | | | | | | | | | | | HPV (girls) |

### Italy

Vaccination Schedule for Italy :
| Infection | Birth | Months | Months | Months | Months | Months | Years | Years | Years |
| Infection | Birth | 3 | 5–6 | 11 | 13 | 15 | 5–6 | 11–18 | 65+ |
| Diphtheria | | D† | D† | D† | D† | | D† | d† | |
| Tetanus | | TT† | TT† | TT† | TT† | | TT† | TT† | |
| Pertussis | | acP† | acP† | acP† | acP† | | acP† | acp† | |
| Polio | | IPV† | IPV† | IPV† | IPV† | | IPV† | | |
| Haemophilus influenzae | | Hib† | Hib† | Hib† | Hib† | | | | |
| Hepatitis B | HepB# | HepB† | HepB† | HepB† | HepB† | | | | |
| Pneumococcus | | PCV† | PCV† | PCV† | PCV† | | | | |
| Meningococcus | | | | | MenC† | MenC† | | MenC‡ | |
| Measles | | | | | MEAS† | MEAS† | MEAS† | MEAS‡ | |
| Mumps | | | | | MUMPS† | MUMPS† | MUMPS† | MUMPS‡ | |
| Rubella | | | | | RUMBE† | RUMBE† | RUMBE† | RUMBE‡ | |
| Varicella | | | | | | | | VAR† | |
| Human papillomavirus | | | | | | | | HPV† | |
| Influenza | | | | | | | | | TIV† |
| † General Recommendation # Recommended for specific groups only. ‡ Catch-up ||||||||||

### Japan

The vaccination schedule in Japan is defined and partially recommended by Immunization Act [ja] (Japanese: 予防接種法) and its related cabinet order [ja] (Japanese: 予防接種法施行令). By the combined laws, infections are categorized into two groups: Category A is recommended for vaccination to prevent pandemic whereas Category B is only for a personal care purpose. As of January 2020, fourteen infections are Category A diseases and two are Category B on the legal lists. The Act and the Order were enacted for mandatory vaccination in 1948 with punitive clauses, only the clauses were repealed in 1976 and eventually vaccination has become non-mandatory since 1994.
Japan Vaccine Schedule: January 2020 :
| Infection | Act/ Order (Category) | Birth | Months | Months | Months | Months | Months | Months | Months | Years | Years | Years | Years | Years | Years | Years | Years | Years |
| Infection | Act/ Order (Category) | Birth | 2 | 3 | 6 | 12 | 24 | 36 | 60 | ≧5 | 7> | 7.5 (90 mo) | 9 | 11 | 12 | 13> | 16 | 60–64 & 65+ |
| Diphtheria | Act (A) | | | DTaP-IPV | DTaP-IPV | DTaP-IPV | DTaP-IPV | DTaP-IPV | DTaP-IPV | DTaP-IPV | DTaP-IPV | DTaP-IPV | | DT | DT | DT | | |
| Tetanus | Act (A) | | | DTaP-IPV | DTaP-IPV | DTaP-IPV | DTaP-IPV | DTaP-IPV | DTaP-IPV | DTaP-IPV | DTaP-IPV | DTaP-IPV | | DT | DT | DT | | |
| Pertussis | Act (A) | | | DTaP-IPV | DTaP-IPV | DTaP-IPV | DTaP-IPV | DTaP-IPV | DTaP-IPV | DTaP-IPV | DTaP-IPV | DTaP-IPV | | | | | | |
| Polio | Act (A) | | | DTaP-IPV | DTaP-IPV | DTaP-IPV | DTaP-IPV | DTaP-IPV | DTaP-IPV | DTaP-IPV | DTaP-IPV | DTaP-IPV | | | | | | |
| Measles | Act (A) | | | | | MR (1st) | MR (1st) | | | MR (2nd) | MR (2nd) | | | | | | | |
| Rubella | Act (A) | | | | | MR (1st) | MR (1st) | | | MR (2nd) | MR (2nd) | | | | | | | |
| Japanese encephalitis | Act (A) | | | | Japanese encephalitis (1st) | Japanese encephalitis (1st) | Japanese encephalitis (1st) | Japanese encephalitis (1st) | Japanese encephalitis (1st) | Japanese encephalitis (1st) | Japanese encephalitis (1st) | Japanese encephalitis (1st) | Japanese encephalitis (2nd) | Japanese encephalitis (2nd) | Japanese encephalitis (2nd) | Japanese encephalitis (2nd) | | |
| Tuberculosis | Act (A) | BCG | BCG | BCG | BCG | BCG | | | | | | | | | | | | |
| Haemophilus influenzae | Act (A) | | Hib | Hib | Hib | Hib | Hib | Hib | Hib | | | | | | | | | |
| Pneumococcus | Act (A) | | Pneumococcal | Pneumococcal | Pneumococcal | Pneumococcal | Pneumococcal | Pneumococcal | Pneumococcal | | | | | | | | | |
| Pneumococcus | Order (B) | | | | | | | | | | | | | | | | | Pneumococcal |
| Human papillomavirus | Act (A) | | | | | | | | | | | | | | HPV vaccine | HPV vaccine | HPV vaccine | |
| Smallpox | Order (A) | Not specified by the act or the order | Not specified by the act or the order | Not specified by the act or the order | Not specified by the act or the order | Not specified by the act or the order | Not specified by the act or the order | Not specified by the act or the order | Not specified by the act or the order | Not specified by the act or the order | Not specified by the act or the order | Not specified by the act or the order | Not specified by the act or the order | Not specified by the act or the order | Not specified by the act or the order | Not specified by the act or the order | Not specified by the act or the order | Not specified by the act or the order |
| Varicella | Order (A) | | | | | Varicella | Varicella | Varicella | | | | | | | | | | |
| Hepatitis B | Order (A) | Hep B | Hep B | Hep B | Hep B | Hep B | | | | | | | | | | | | |
| Influenza | Order (B) | | | | | | | | | | | | | | | | | Flu |
| 1 2 Vaccines for measles and rubella (MR vaccine) can be received anytime from 5 y/o before 7 y/o, AND the time should be also between one year and one day before the first day of schooling (quote: "五歳以上七歳未満の者であって、小学校就学の始期に達する日の一年前の日から当該始期に達する日の前日までの間にあるもの". 1 2 HPV for female students only. Vaccination can be started from the first day of school year within she turns 12, and until the last day of school year within she turns 16 (quote: "十二歳となる日の属する年度の初日から十六歳となる日の属する年度の末日までの間にある女子"). ↑ Age 60–64 with certain diseases: heart, kidney or respitory failures, or with an immune-related disorder due to HIV infection. |||||||||||||||||||
Only in the legal term in Japan, citizens get old one day before their birthdays. If a person was born on January 1, 2020, and Immunization Act specifies vaccine against measles could be received from age 12 months to 24 months, vaccination shall be practiced between December 31, 2020, and December 31, 2021 (not between January 2021 and January 2022.) Some vaccinations are scheduled in line with the school year system, which starts from April 1 in Japan. As explained, those who born on April 1 and on April 2 get old legally on March 31 and April 1, respectively. Thus, these two people are in different school years and thereby they may take vaccines in different calendar years.
Legal age counting system in Japan :
| Recipients | Birth | Months | Months | Months | Months | Months | Months | Months | Years | Years | Years | Years | Years | Years | Years | Years |
| Recipients | Birth | 2 | 3 | 6 | 12 | 24 | 36 | 60 | ≧5 | 7> | 7.5 (90 mo) | 9 | 11 | 12 | 13> | 16 |
| Person A | Dec 31, 2019 | Feb 29, 2020 | Mar 30, 2020 | Jun 30, 2020 | Dec 30, 2020 | Dec 30, 2021 | Dec 30, 2022 | Dec 30, 2024 | Apr 1, 2025 | Mar 31, 2026 | Jun 30, 2027 | Dec 30, 2028 | Dec 30, 2030 | Apr 1, 2031 | Dec 29, 2032 | Mar 31, 2036 |
| Person B | Jan 1, 2020 | Feb 29, 2020 | Mar 31, 2020 | Jun 30, 2020 | Dec 31, 2020 | Dec 31, 2021 | Dec 31, 2022 | Dec 31, 2024 | Apr 1, 2025 | Mar 31, 2026 | Jun 30, 2027 | Dec 31, 2028 | Dec 31, 2030 | Apr 1, 2031 | Dec 30, 2032 | Mar 31, 2036 |
| Person C | Apr 1, 2020 | May 31, 2020 | Jun 31, 2020 | Sep 30, 2020 | Mar 31, 2021 | Mar 31, 2022 | Mar 31, 2023 | Mar 31, 2025 | Apr 1, 2025 | Mar 31, 2026 | Sep 30, 2027 | Mar 31, 2029 | Mar 31, 2031 | Apr 1, 2031 | Mar 30, 2033 | Mar 31, 2036 |
| Person D | Apr 2, 2020 | Jun 1, 2020 | Jul 1, 2020 | Oct 1, 2020 | Apr 1, 2021 | Apr 1, 2022 | Apr 1, 2023 | Apr 1, 2025 | Apr 1, 2026 | Mar 31, 2027 | Oct 1, 2027 | Apr 1, 2029 | Apr 1, 2031 | Apr 1, 2032 | Mar 31, 2033 | Mar 31, 2037 |
| 1 2 Vaccines for measles and rubella (MR vaccine) can be received anytime from 5 y/o before 7 y/o, AND the time should be also between one year and one day before the first day of schooling (quote: "五歳以上七歳未満の者であって、小学校就学の始期に達する日の一年前の日から当該始期に達する日の前日までの間にあるもの". 1 2 HPV for female students only. Vaccination can be started from the first day of school year within she turns 12, and until the last day of school year within she turns 16 (quote: "十二歳となる日の属する年度の初日から十六歳となる日の属する年度の末日までの間にある女子"). 1 2 3 Starts elementary schooling from April 1, 2026 1 2 2020 is a leap year. Person B socially turns 2 months old on March 1, 2004. In the legal term, however, Person B's 2-month birthday is the day before March 1, 2004. Thus, It shall be February 29, 2004. There are no February 30 or 31 in 2020. As a result Person A and Person B have the same 2-month birthday. ↑ Starts elementary schooling from April 1, 2027 |||||||||||||||||

### New Zealand

New Zealand Immunization Schedule: 1 October 2020 :
| Infection | Gestation | Weeks | Months | Months | Months | Months | Years | Years | Years | Years |
| Infection | Gestation | 6 | 3 | 5 | 12 | 15 | 4 | 11–12 | 45 | 65+ |
| Rotavirus | | RV | RV | | | | | | | |
| Diphtheria | Tdap | DTaP-HepB-IPV-Hib | DTaP-HepB-IPV-Hib | DTaP-HepB-IPV-Hib | | | DTaP-IPV | Tdap | Tdap | Tdap |
| Tetanus | Tdap | DTaP-HepB-IPV-Hib | DTaP-HepB-IPV-Hib | DTaP-HepB-IPV-Hib | | | DTaP-IPV | Tdap | Tdap | Tdap |
| Pertussis | Tdap | DTaP-HepB-IPV-Hib | DTaP-HepB-IPV-Hib | DTaP-HepB-IPV-Hib | | | DTaP-IPV | Tdap | Tdap | Tdap |
| Polio | | DTaP-HepB-IPV-Hib | DTaP-HepB-IPV-Hib | DTaP-HepB-IPV-Hib | | | DTaP-IPV | | | |
| Hepatitis B | | DTaP-HepB-IPV-Hib | DTaP-HepB-IPV-Hib | DTaP-HepB-IPV-Hib | | | | | | |
| Haemophilus influenzae | | DTaP-HepB-IPV-Hib | DTaP-HepB-IPV-Hib | DTaP-HepB-IPV-Hib | | Hib | | | | |
| Pneumococcus | | PCV10 | | PCV10 | PCV10 | | | | | |
| Measles | | | | | MMR | MMR | | | | |
| Mumps | | | | | MMR | MMR | | | | |
| Rubella | | | | | MMR | MMR | | | | |
| Varicella | | | | | | VV | | VV | | |
| Human papillomavirus | | | | | | | | HPV9 | | |
| Herpes Zoster | | | | | | | | | | HZ |
| Influenza | IIV | | | | | | | | | IIV (yearly) |
| ↑ Only if the person has not previously received the varicella vaccine or had a varicella infection |||||||||||

#### History

Major additions, replacements and removals from the New Zealand Immunization Schedule include:
    1958: First Schedule: DTwP and DT
    1961: Polio (OPV) added
    1971: Measles, rubella and tetanus toxoid added
    1979: Rubella changed to girls only
    1988: HepB added
    1990: MMR replaced measles and rubella
    1994: HIB added; Td replaced tetanus toxoid
    1996: DT dropped
    1997: Influenza added
    2000: DTaP replaced DTwP
    2002: IPV replaced OPV
    2006: MeNZB and Tdap added
    2008: MeNZB dropped, PCV7 added, HPV4 added for females only
    2011: PCV10 replaced PCV7
    2014: RV5 added, PCV13 replaced PCV10
    2017: HPV9 replaced HPV4 and extended to males, RV1 replaced RV5, PCV10 replaced PCV13, VV added.
    2018: HZ added.
    2020: Td dropped.

### Nigeria

All recommended vaccines are provide free of charge by the Federal Ministry of Health.
Nigerian National Vaccination Schedule: :
| Infection | Birth | Months | Months | Months | Months | Months | Months | Years | Years |
| Infection | Birth | 2 | 3 | 4 | 6 | 9 | 18 | 4 | 5 |
| Tuberculosis | BCG | | | | | | | | |
| Leprosy | BCG | | | | | | | | |
| Hepatitis B | HepB | 5V | | 5V | 5V | | | | |
| Diphtheria | | 5V | | 5V | 5V | | DTP | | |
| Tetanus | | 5V | | 5V | 5V | | DTP | | |
| Pertussis | | 5V | | 5V | 5V | | DTP | | |
| Haemophilus influenzae | | 5V | | 5V | 5V | | | | |
| Polio | OPV | OPV | OPV | OPV | | | OPV | OPV | |
| Pneumococcus | | PCV | PCV | PCV | | PCV | | | |
| Meningococcus | | | | | | | MCV | MCV | |
| Yellow fever | | | | | | YF | | | |

### Spain

Vaccination Schedule for Spain :
| Infection | Birth | Months | Months | Months | Months | Months | Years | Years | Years | Years | Years |
| Infection | Birth | 2 | 4 | 6 | 12 | 18 | 3–4 | 6 | 12 | 14 | 65+ |
| Diphtheria | | D† | D† | D† | | D† | | d† | | d† | d† |
| Tetanus | | TT† | TT† | TT† | | TT† | | TT† | | TT† | TT† |
| Pertussis | | acP† | acP† | acP† | | acP† | | acp† | | | |
| Polio | | IPV† | IPV† | IPV† | | IPV† | | | | | |
| Haemophilus influenzae | | Hib† | Hib† | Hib† | | Hib† | | | | | |
| Hepatitis B | HepB† | HepB† | HepB† | | | | | | | | |
| Pneumococcus | | PCV† | PCV† | | PCV† | | | | | | PPSV23† |
| Meningococcus | | MenC† | | | MenC† | | | | MenC† | | |
| Measles | | | | | MEAS† | | MEAS† | | | | |
| Mumps | | | | | MUMPS† | | MUMPS† | | | | |
| Rubella | | | | | RUMBE† | | RUMBE† | | | | |
| Varicella | | | | | | | | | VAR† | | |
| Human papillomavirus | | | | | | | | | HPV† | | |
| Influenza | | | | | | | | | | | TIV† |
| † General Recommendation # Recommended for specific groups only. ‡ Catch-up ||||||||||||

### United Kingdom

The United Kingdom childhood vaccination schedule is recommended by the Department of Health and National Health Service, and uses combination immunisations where available.
United Kingdom Vaccine Schedule: 2020 :
| Infection | Months | Months | Months | Months | Years | Years | Years | Years | Years |
| Infection | 2 | 3 | 4 | 12 | 2–10 | 3–4 | 12–13 | 13–15 | 16–18 |
| Diphtheria | DTaP | DTaP | DTaP | | | DTaP | | Td | Td |
| Tetanus | DTaP | DTaP | DTaP | | | DTaP | | Td | Td |
| Pertussis | DTaP | DTaP | DTaP | | | DTaP | | | |
| Polio | IPV | IPV | IPV | | | IPV | | IPV | |
| Haemophilus influenzae | HIB | HIB | HIB | HIB | | | | | |
| Meningococcus | MenB | | MenB | MenB/C | | | | MenACWY | |
| Rotavirus | RV | RV | | | | | | | |
| Pneumococcus | | PCV | | PCV | | | | | |
| Hepatitis B | HepB | HepB | HepB | | | | | | |
| Measles | | | | MMR | | MMR | | | |
| Mumps | | | | MMR | | MMR | | | |
| Rubella | | | | MMR | | MMR | | | |
| Influenza | | | | | LAIV | | | | |
| HPV | | | | | | | HPVx2 | |

#### Non-routine vaccinations

Some children may receive vaccines in addition to those listed in the table:
* BCG vaccine is given at birth to "children born in areas of the country where there are high numbers of TB cases" and "children whose parents or grandparents were born in a country with many cases of TB."
* Hepatitis B vaccine is given at birth to "babies born to mothers who have hepatitis B".
* The injected flu vaccine is offered annually to "children 6 months to 17 years old with long-term health conditions".

#### Adult vaccinations

The five scheduled childhood tetanus vaccinations are thought to generally confer lifelong immunity; thus, no routine booster doses are given in adulthood. Those adults at risk of contaminated cuts (e.g., gardeners) may have booster tetanus vaccination every ten years. Pneumococcus vaccinations (pneumococcal polysaccharide vaccine/PPV) are recommended for those over 65 and for people without a functional spleen (asplenia), either because the spleen has been removed or does not work properly. Flu vaccine is recommended for anyone who is aged 65 years and over, people with certain long-term medical conditions, health and social care professionals, pregnant women, and poultry workers. The shingles vaccine is recommended for those over 70. Additionally, pregnant women are advised to have the pertussis vaccine.

### United States

The most up-to-date schedules are available from CDC's National Center for Immunization and Respiratory Diseases. In the US, the National Childhood Vaccine Injury Act requires all health-care providers to provide parents or patients with copies of Vaccine Information Statements before administering vaccines.
Vaccine Schedule for the United States: 2020 :
| Infection | Birth | Months | Months | Months | Months | Months | Months | Months | Months | Months | Years | Years | Years | Years | Years | Years | Years | Years | Years | Years | Years |
| Infection | Birth | 1 | 2 | 4 | 6 | 9 | 12 | 15 | 18 | 19–23 | 2–3 | 4–6 | 7–10 | 11–12 | 13–15 | 16 | 17–18 | 19–26 | 27–49 | 50–64 | 65+ |
| Hepatitis B | HepB† | HepB† | HepB† | HepB‡ | HepB† | HepB† | HepB† | HepB† | HepB† | HepB‡ | HepB‡ | HepB‡ | HepB‡ | HepB‡ | HepB‡ | HepB‡ | HepB‡ | HepB x2–3# | HepB x2–3# | HepB x2–3# | HepB x2–3# |
| Rotavirus | | | RV† | RV† | RV† | | | | | | | | | | | | | | | | |
| Diphtheria | | | DTaP† | DTaP† | DTaP† | DTaP‡ | DTaP‡ | DTaP† | DTaP† | DTaP‡ | DTaP‡ | DTaP† | Tdap‡ | Tdap† | Tdap‡ | Tdap‡ | Tdap‡ | Td or Tdap (every 10 years)† | Td or Tdap (every 10 years)† | Td or Tdap (every 10 years)† | Td or Tdap (every 10 years)† |
| Tetanus | | | DTaP† | DTaP† | DTaP† | DTaP‡ | DTaP‡ | DTaP† | DTaP† | DTaP‡ | DTaP‡ | DTaP† | Tdap‡ | Tdap† | Tdap‡ | Tdap‡ | Tdap‡ | Td or Tdap (every 10 years)† | Td or Tdap (every 10 years)† | Td or Tdap (every 10 years)† | Td or Tdap (every 10 years)† |
| Pertussis | | | DTaP† | DTaP† | DTaP† | DTaP‡ | DTaP‡ | DTaP† | DTaP† | DTaP‡ | DTaP‡ | DTaP† | Tdap‡ | Tdap† | Tdap‡ | Tdap‡ | Tdap‡ | Td or Tdap (every 10 years)† | Td or Tdap (every 10 years)† | Td or Tdap (every 10 years)† | Td or Tdap (every 10 years)† |
| Haemophilus influenzae | | | Hib† | Hib† | Hib† | Hib‡ | Hib† | Hib† | Hib‡ | Hib‡ | Hib‡ | Hib‡ | Hib# | Hib# | Hib# | Hib# | Hib# | Hib x1–3# | Hib x1–3# | Hib x1–3# | Hib x1–3# |
| Polio | | | IPV† | IPV† | IPV† | IPV† | IPV† | IPV† | IPV† | IPV‡ | IPV‡ | IPV† | IPV‡ | IPV‡ | IPV‡ | IPV‡ | IPV‡ | | | | |
| Pneumococcus | | | PCV13† | PCV13† | PCV13† | PCV13‡ | PCV13† | PCV13† | PCV13‡ | PCV13‡ | PCV13‡ | PCV13‡ | PCV13# | PCV13# | PCV13# | PCV13# | PCV13# | PCV13# | PCV13# | PCV13# | PCV13§ |
| Pneumococcus | | | | | | | | | | | PPSV23# | PPSV23# | PPSV23# | PPSV23# | PPSV23# | PPSV23# | PPSV23# | PPSV23 x1–2# | PPSV23 x1–2# | PPSV23 x1–2# | PPSV23† |
| Influenza | | | | | IIV (yearly)† | IIV (yearly)† | IIV (yearly)† | IIV (yearly)† | IIV (yearly)† | IIV (yearly)† | IIV or LAIV (yearly)† | IIV or LAIV (yearly)† | IIV or LAIV (yearly)† | IIV or LAIV (yearly)† | IIV or LAIV (yearly)† | IIV or LAIV (yearly)† | IIV or LAIV (yearly)† | IIV or LAIV (yearly)† | IIV or LAIV (yearly)† | IIV or LAIV (yearly)† | IIV or LAIV (yearly)† |
| Measles | | | | | MMR# | MMR# | MMR† | MMR† | MMR‡ | MMR‡ | MMR‡ | MMR† | MMR‡ | MMR‡ | MMR‡ | MMR‡ | MMR‡ | MMR x1–2‡ | MMR x1–2‡ | MMR x1–2‡ | |
| Mumps | | | | | MMR# | MMR# | MMR† | MMR† | MMR‡ | MMR‡ | MMR‡ | MMR† | MMR‡ | MMR‡ | MMR‡ | MMR‡ | MMR‡ | MMR x1–2‡ | MMR x1–2‡ | MMR x1–2‡ | |
| Rubella | | | | | MMR# | MMR# | MMR† | MMR† | MMR‡ | MMR‡ | MMR‡ | MMR† | MMR‡ | MMR‡ | MMR‡ | MMR‡ | MMR‡ | MMR x1–2‡ | MMR x1–2‡ | MMR x1–2‡ | |
| Varicella | | | | | | | VAR† | VAR† | VAR‡ | VAR‡ | VAR‡ | VAR† | VAR‡ | VAR‡ | VAR‡ | VAR‡ | VAR‡ | VAR x1–2‡ | VAR x1–2‡ | VAR 2x# | VAR 2x# |
| Hepatitis A | | | | | HepA# | HepA# | HepA x2† | HepA x2† | HepA x2† | HepA x2† | HepA‡ | HepA‡ | HepA‡ | HepA‡ | HepA‡ | HepA‡ | HepA‡ | HepA x2–3# | HepA x2–3# | HepA x2–3# | HepA x2–3# |
| Meningococcus | | | MenACWY# | MenACWY# | MenACWY# | MenACWY# | MenACWY# | MenACWY# | MenACWY# | MenACWY# | MenACWY# | MenACWY# | MenACWY# | MenACWY† | MenACWY‡ | MenACWY† | MenACWY‡ | MenACWY x1–2# | MenACWY x1–2# | MenACWY x1–2# | MenACWY x1–2# |
| Meningococcus | | | | | | | | | | | | | | MenB x2–3# | MenB x2–3# | MenB x2–3# | MenB x2–3# | MenB x2–3# | MenB x2–3# | MenB x2–3# | MenB x2–3# |
| Meningococcus | | | | | | | | | | | | | | | | | MenB§ | MenB§ | | | |
| Human papillomavirus | | | | | | | | | | | | | HPV# | HPV x2–3† | HPV‡ | HPV‡ | HPV‡ | HPV‡ | HPV§ | | |
| Herpes Zoster | | | | | | | | | | | | | | | | | | | | RZV or ZVL† |
| † Range of recommended ages for everyone. See references for more details. # Range of recommended ages for certain high-risk groups. See references for more details. ‡ Range of recommended ages for catch-up immunization or for people who lack evidence of immunity (e.g., lack documentation of vaccination or have no evidence of prior infection). § Recommended vaccination based on shared clinical decision-making. ↑ CDC provides more detailed information in catch-up immunizations. ||||||||||||||||||||||

#### During pregnancy

The CDC recommends pregnant women receive some vaccines, such as the measles, mumps, rubella (MMR) vaccine a month or more before pregnancy. The Tdap vaccine (to help protect against whooping cough) is recommended during pregnancy. Other vaccines, like the flu shot, can be given before or during pregnancy, depending on whether or not it is flu season. Vaccination is safe right after giving birth, even while breastfeeding.

## History

In 1900, the smallpox vaccine was the only one administered to children. By the early 1950s, children routinely received three vaccines, for protection against diphtheria, pertussis, tetanus, and smallpox, and as many as five shots by two years of age. Since the mid-1980s, many vaccines have been added to the schedule. In 2009, the U.S. Centers for Disease Control and Prevention (CDC) recommended vaccination against at least fourteen diseases. By two years of age, U.S. children receive as many as 24 vaccine injections, and might receive up to five shots during one visit to the doctor. The use of combination vaccine products means that, as of 2013, the United Kingdom's immunization program consists of nine injections by the age of two, rather than 22 if vaccination for each disease was given as a separate injection.